• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由细胞结合型流感嗜血杆菌引起的支气管肺炎的新型小鼠模型。

New murine model of bronchopneumonia due to cell-bound Haemophilus influenzae.

作者信息

Miyazaki S, Nunoya T, Matsumoto T, Tateda K, Yamaguchi K

机构信息

Department of Microbiology, School of Medicine, Toho University, Tokyo, Japan.

出版信息

J Infect Dis. 1997 Jan;175(1):205-9. doi: 10.1093/infdis/175.1.205.

DOI:10.1093/infdis/175.1.205
PMID:8985222
Abstract

This murine model of nontypeable (unencapsulated) Haemophilus influenzae (NTHI) bronchopneumonia used organisms bound to mouse fetal lung (MFL) cells as an inoculum. Pretreatment of the mice with 40 microL of 1% formalin 3 days before intranasal instillation of the bacteria was necessary to allow infection. The number of NTHI recovered from the lungs plus trachea on day 7 after instillation was >100 times the number originally inoculated. Later, however, the number of recovered bacteria diminished gradually, and by day 14 it was almost identical to the original inoculum size. Serum IgM also peaked on day 7 after infection, after which IgG increased while IgM decreased. Histologically, bronchoalveolar infiltration of neutrophils was observed on day 3 after inoculation and continued at least for the following 4 days. The present experiment demonstrates that MFL cells can protect bacteria that have invaded the cells from the opsonizing and killing activities of host humoral defense mechanisms.

摘要

这种不可分型(无荚膜)流感嗜血杆菌(NTHI)支气管肺炎的小鼠模型使用与小鼠胎肺(MFL)细胞结合的细菌作为接种物。在鼻内滴注细菌前3天用40微升1%福尔马林预处理小鼠对于感染是必要的。滴注后第7天从肺和气管中回收的NTHI数量比最初接种的数量多100倍以上。然而,后来回收的细菌数量逐渐减少,到第14天时几乎与最初接种物的大小相同。血清IgM在感染后第7天也达到峰值,之后IgG增加而IgM减少。组织学上,接种后第3天观察到中性粒细胞的支气管肺泡浸润,并至少持续接下来的4天。本实验表明,MFL细胞可以保护侵入细胞的细菌免受宿主体液防御机制的调理和杀伤活性的影响。

相似文献

1
New murine model of bronchopneumonia due to cell-bound Haemophilus influenzae.由细胞结合型流感嗜血杆菌引起的支气管肺炎的新型小鼠模型。
J Infect Dis. 1997 Jan;175(1):205-9. doi: 10.1093/infdis/175.1.205.
2
In vivo efficacy of sitafloxacin in a new murine model of non-typeable Haemophilus influenzae pneumonia by sterile intratracheal tube.西他沙星在通过无菌气管内导管建立的新型非分型流感嗜血杆菌肺炎小鼠模型中的体内疗效。
Int J Antimicrob Agents. 2009 Sep;34(3):210-4. doi: 10.1016/j.ijantimicag.2009.03.011. Epub 2009 Apr 24.
3
Sialic Acid Protects Nontypeable Haemophilus influenzae from Natural IgM and Promotes Survival in Murine Respiratory Tract.唾液酸保护非分型流感嗜血杆菌免受天然 IgM 攻击并促进其在小鼠呼吸道中的存活。
Infect Immun. 2021 May 17;89(6). doi: 10.1128/IAI.00676-20.
4
Experimental pulmonary infection and colonization of Haemophilus influenzae in emphysematous hamsters.实验性肺气肿仓鼠感染流感嗜血杆菌及其定植。
Pulm Pharmacol Ther. 2010 Aug;23(4):292-9. doi: 10.1016/j.pupt.2010.02.006. Epub 2010 Mar 6.
5
Interleukin 18 participates in the early inflammatory response and bacterial clearance during pneumonia caused by nontypeable Haemophilus influenzae.白细胞介素18参与了由不可分型流感嗜血杆菌引起的肺炎期间的早期炎症反应和细菌清除过程。
Infect Immun. 2007 Oct;75(10):5068-72. doi: 10.1128/IAI.00287-07. Epub 2007 Jul 30.
6
Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung.细菌感染期间表面活性蛋白A或D缺乏对肺部的不同影响。
J Immunol. 2000 Oct 1;165(7):3934-40. doi: 10.4049/jimmunol.165.7.3934.
7
Lipooligosaccharides containing phosphorylcholine delay pulmonary clearance of nontypeable Haemophilus influenzae.含有磷酰胆碱的脂寡糖会延迟不可分型流感嗜血杆菌的肺部清除。
Infect Immun. 2008 May;76(5):2037-43. doi: 10.1128/IAI.01716-07. Epub 2008 Mar 17.
8
PHiD-CV induces anti-Protein D antibodies but does not augment pulmonary clearance of nontypeable Haemophilus influenzae in mice.10-荚膜肺炎球菌结合疫苗诱导抗D蛋白抗体,但不会增强小鼠体内不可分型流感嗜血杆菌的肺部清除能力。
Vaccine. 2015 Sep 11;33(38):4954-61. doi: 10.1016/j.vaccine.2015.07.034. Epub 2015 Jul 26.
9
A rat model of prolonged pulmonary infection due to nontypable Haemophilus influenzae.
Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1429-35. doi: 10.1164/ajrccm/142.6_Pt_1.1429.
10
Recognition of conserved antigens by Th17 cells provides broad protection against pulmonary infection.Th17 细胞识别保守抗原可提供针对肺部感染的广泛保护。
Proc Natl Acad Sci U S A. 2018 Jul 24;115(30):E7149-E7157. doi: 10.1073/pnas.1802261115. Epub 2018 Jul 9.

引用本文的文献

1
Zyxin modulates the transmigration of Haemophilus influenzae to the central nervous system.斑联蛋白调节流感嗜血杆菌向中枢神经系统的迁移。
Virulence. 2014 Aug 15;5(6):665-72. doi: 10.4161/viru.29786. Epub 2014 Jul 15.
2
Comparative efficacies of different antibiotic treatments to eradicate nontypeable Haemophilus influenzae infection.不同抗生素治疗方案根除非分型流感嗜血杆菌感染的疗效比较
BMC Infect Dis. 2008 Feb 7;8:15. doi: 10.1186/1471-2334-8-15.
3
In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae.
泰利霉素(HMR3647)对肺炎链球菌和流感嗜血杆菌的体内疗效。
Antimicrob Agents Chemother. 2001 Nov;45(11):3250-2. doi: 10.1128/AAC.45.11.3250-3252.2001.
4
Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.2000年慢性阻塞性肺疾病中的细菌感染:最新综述
Clin Microbiol Rev. 2001 Apr;14(2):336-63. doi: 10.1128/CMR.14.2.336-363.2001.
5
In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections.新型口服碳青霉烯类药物L-084对呼吸道感染病原菌的体内外抗菌活性
Antimicrob Agents Chemother. 2001 Jan;45(1):203-7. doi: 10.1128/AAC.45.1.203-207.2001.
6
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.新型氟喹诺酮类药物HSR-903对呼吸道病原体的体内活性
Antimicrob Agents Chemother. 1998 Apr;42(4):785-8. doi: 10.1128/AAC.42.4.785.
7
In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem.新型口服碳青霉烯类药物CS-834的体外和体内抗菌活性
Antimicrob Agents Chemother. 1998 Mar;42(3):555-63. doi: 10.1128/AAC.42.3.555.
8
In vitro and in vivo antibacterial activities of CS-940, a new fluoroquinolone, against isolates from patients with respiratory infections.新型氟喹诺酮类药物CS - 940对呼吸道感染患者分离菌株的体内外抗菌活性
Antimicrob Agents Chemother. 1997 Nov;41(11):2582-5. doi: 10.1128/AAC.41.11.2582.